These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6804601)

  • 1. Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline.
    Ben-Menachem E; Johansson BB; Svensson TH
    J Neural Transm; 1982; 53(2-3):159-67. PubMed ID: 6804601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenic modification of the vulnerability of the blood-brain barrier during acute hypertension in conscious rats.
    Johansson BB; Auer LM
    Acta Physiol Scand; 1983 Apr; 117(4):507-11. PubMed ID: 6410686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal 6-hydroxydopamine treatment increases the vulnerability of the blood-brain barrier to acute hypertension in conscious rats.
    Johansson BB
    Acta Neurol Scand; 1979 Oct; 60(4):198-203. PubMed ID: 43065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier to albumin in awake rats in acute hypertension induced by adrenaline, noradrenaline or angiotensin.
    Johansson BB; Martinsson L
    Acta Neurol Scand; 1979 Oct; 60(4):193-7. PubMed ID: 43064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
    van den Buuse M; Versteeq DH; de Jong W
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between noradrenergic and serotonergic mechanisms on the central regulation of blood pressure in the rat: a study using experimental central hypertension produced by chemical lesions of the locus coeruleus.
    Ogawa M
    Jpn Circ J; 1978 May; 42(5):581-97. PubMed ID: 151755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-hydroxydopamine and the PNMT inhibitor LY134046 on pressor responses to stimulation of the subretrofacial nucleus in anaesthetized stroke-prone spontaneously hypertensive rats.
    Head GA; Howe PR
    J Auton Nerv Syst; 1987 Mar; 18(3):213-24. PubMed ID: 3106455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do nitrous oxide and lidocaine modify the blood-brain barrier in acute hypertension in the rat?
    Johansson BB; Linder LE
    Acta Anaesthesiol Scand; 1980; 24(1):65-8. PubMed ID: 7376807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat.
    van den Buuse M; Versteeg DH; de Jong W
    Brain Res; 1986 Mar; 368(1):69-78. PubMed ID: 3006867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat.
    Janss AJ; Jones SL; Gebhart GF
    Brain Res; 1987 Jan; 400(1):40-52. PubMed ID: 3101973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central depletion of catecholamines--importance of hypertension and anesthesia.
    Woodside JR; Beckman JJ; Althaus JS; Miller ED
    Anesth Analg; 1984 May; 63(5):482-8. PubMed ID: 6424508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental central hypertension produced by chemical degeneration of the locus coeruleus in the rat.
    Ogawa M; Fujita Y; Ozaki M
    Jpn Circ J; 1979 Feb; 43(2):89-98. PubMed ID: 36487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular permeability to horseradish peroxidase in hypertensive rats: effects of unilateral locus ceruleus lesion.
    Nag S; Harik SI
    Acta Neuropathol; 1987; 73(3):247-53. PubMed ID: 3113166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat.
    Blue ME; Molliver ME
    Brain Res; 1987 Apr; 429(2):255-69. PubMed ID: 3105821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of depletion of spinal noradrenaline by 6-hydroxydopamine on the development of renal hypertension in rats.
    Bosland MC; Versteeg DH; van Put J; de Jong W
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):67-77. PubMed ID: 7471522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral 6-hydroxydopamine produces extensive damage to the blood-brain barrier in rats.
    Cooper PH; Novin D; Butcher LL
    Neurosci Lett; 1982 May; 30(1):13-8. PubMed ID: 6808424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.